论文部分内容阅读
目的探讨依达拉奉治疗急性脑出血的临床疗效。方法 72例急性脑出血患者随机分为对照组与治疗组,每组各36例,均行常规治疗,治疗组给予依达拉奉治疗,分析两组临床疗效。结果对照组总有效率75.0%,治疗组总有效率91.7%;治疗后治疗组日常生活活动Barthel指数评分显著优于对照组(P<0.05)。结论依达拉奉治疗急性脑出血可显著改善患者的预后。
Objective To investigate the clinical efficacy of edaravone in the treatment of acute cerebral hemorrhage. Methods A total of 72 patients with acute cerebral hemorrhage were randomly divided into control group and treatment group, 36 cases in each group. All patients underwent routine treatment. The treatment group was treated with edaravone, and the clinical efficacy was analyzed. Results The total effective rate of the control group was 75.0%, and the total effective rate of the treatment group was 91.7%. The Barthel index of the daily living activities of the treatment group was significantly better than that of the control group after treatment (P <0.05). Conclusion Edaravone in the treatment of acute cerebral hemorrhage can significantly improve the prognosis of patients.